Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Microneedles Enhance Drug Administration With Patches Posted: Thursday, February 14, 2008

Microneedle technology will increase the availability of medications applicable for transdermal drug delivery, a pain free and patient friendly route of drug administration.

Intensive Insulin Therapy Protects Kidneys In The Critically Ill Posted: Thursday, February 14, 2008

For critically ill patients, intensive insulin therapy (IIT) to keep blood sugar (glucose) at normal levels reduces the risk of acute kidney injury, reports a new study.

Steno-2 Study Finds Aggressive Diabetes Therapy Lowers Death Risk Posted: Thursday, February 14, 2008

People with type 2 diabetes who are already showing signs of some kidney damage may be able to significantly lower their risk of death by treating multiple risk factors at once.

Resistance to Aspirin Increases Cardiovascular Event Risk Posted: Thursday, February 07, 2008

Patients ostensibly resistant to aspirin face significantly increased rates of life-threatening cardiovascular events, a meta-analysis has found.

Diuretics Comparable or Better Than Other Drugs for Hypertension Posted: Thursday, February 07, 2008

Use of calcium-channel blockers, alpha-blockers or angiotensin-converting enzyme (ACE) inhibitors appears to offer no advantages in improving clinical outcomes compared with use of diuretics when treating hypertension among individuals with metabolic syndrome. Even more so for black patients.

Old Anti-Inflammatory Drug May Prevent And Treat Type 2 Diabetes Posted: Thursday, February 07, 2008

Researchers are reporting that an inexpensive anti-inflammatory drug similar to aspirin, salsalate, may prevent type 2 diabetes by lowering blood glucose 13 percent and reducing inflammation by 34 percent.

Endocrinologist Shortage Represents Significant Threat to Public Health Posted: Thursday, February 07, 2008

A new analysis supports what many in the healthcare field already suspect, that demand for endocrinologists in the United States far exceeds supply, and this shortfall in medical care will only get worse in the coming years.

FDA Approves New Continuous Glucose Monitoring System Posted: Thursday, February 07, 2008

Medtronic Inc said U.S. health regulators approved its blood sugar monitoring device, the CGMS iPro Recorder. The U.S. medical device maker said patients wear the device for three days, after which physicians can review the data and use the results to uncover glucose patterns.

Testosterone Reduces Visceral Fat Gain in Nonobese Older Men Posted: Thursday, February 07, 2008

Researchers report, that testosterone therapy lessens the gain in visceral adipose tissue and the loss of skeletal muscle in aging men who are not obese.

Does L-Arginine Supplementation Make A Difference? Posted: Thursday, February 07, 2008

Researchers have found that diabetes creates too much competition for an amino acid called L-arginine that helps blood vessels to relax.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.